,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,71636,5369664,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,71636,5369664,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,71636,5369664,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,71636,5369664,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,71636,5369664,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,71636,5369664,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,179,1,1,,498392,5369664,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
7,330,1,1,,71636,5369664,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
8,880,2,1,,26755066,5369664,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
9,880,2,1,,26755066,5369664,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
10,894,2,1,,26755066,5369664,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
11,1030,2,1,,26755066,5369664,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
12,1379,1,2,,26755066,5369664,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
13,1452,1,1,,26755066,5369664,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
14,1454,1,1,,26755066,5369664,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
15,1457,1,1,,26755066,5369664,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
16,1458,1,1,,26755066,5369664,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
17,1460,1,3,,26755066,5369664,Inconclusive,92096784.0,4137.0,39.8107,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
18,1463,1,1,,26755066,5369664,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
19,1467,1,3,,26755066,5369664,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
20,1468,1,1,,26755066,5369664,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
21,1469,1,1,,26755066,5369664,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
22,1471,2,1,,26755066,5369664,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
23,1476,2,1,,26755066,5369664,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
24,1477,1,1,,26755066,5369664,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
25,1478,2,1,,26755066,5369664,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
26,1479,1,2,,26755066,5369664,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
27,1490,2,1,,26755066,5369664,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
28,1766,1,1,,26755066,5369664,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
29,1766,1,1,,26755066,5369664,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
30,1768,1,1,,26755066,5369664,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
31,1768,1,1,,26755066,5369664,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
32,1865,1,1,,26755066,5369664,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
33,2101,1,1,,26755066,5369664,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
34,2107,1,1,,26755066,5369664,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
35,2112,1,1,,26755066,5369664,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
36,2147,1,1,,26755066,5369664,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
37,2451,1,2,,26755066,5369664,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
38,2472,1,2,,26755066,5369664,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
39,2517,2,1,,26755066,5369664,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
40,2528,1,2,,26755066,5369664,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
41,2546,1,1,,26755066,5369664,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
42,2549,1,1,,26755066,5369664,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
43,2551,1,1,,26755066,5369664,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
44,45824,6,2,,103324254,5369664,Active,,,8.9,IC50,Inhibitory concentration against CEM T-lymphocytes,Confirmatory,12086496.0,
45,125184,6,2,,103324254,5369664,Active,,,8.53,IC50,Inhibitory concentration against proliferation of human Molt 4/C8 cells,Confirmatory,12086496.0,
46,221024,6,2,,103324254,5369664,Unspecified,,,82.9,IC50,Inhibitory activity against L1210 leukemia cells,Confirmatory,12086496.0,
47,224732,6,2,,103324254,5369664,Active,,,15.3,IC50,Inhibitory activity against Murine P388 cells,Confirmatory,12086496.0,
48,485290,1,1,,26755066,5369664,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
49,504847,1,1,,26755066,5369664,Active,63054845.0,7421.0,19.9526,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
50,540276,1,2,,26755066,5369664,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
51,655021,1,8,,103324254,5369664,Unspecified,1018618719.0,367.0,,,Antagonist activity at androgen receptor in human LNCAP cells assessed as decrease in prostate specific antigen mRNA level at 2.5 uM after 20 hrs by real time RT-PCR analysis relative to control,Other,22310230.0,
52,720532,1,1,,26755066,5369664,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
53,720533,1,1,,26755066,5369664,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
54,1095451,1,2,,103324254,5369664,Unspecified,,,,,Toxicity against third instar larve of Culex quinquefasciatus after 24 hr,Other,,
55,1173788,1,2,,103324254,5369664,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry,Other,25456077.0,
56,1173789,1,2,,103324254,5369664,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 3 hrs by spectrophotometry,Other,25456077.0,
57,1173791,1,1,,103324254,5369664,Unspecified,,,,,Metal chelating activity of the compound assessed as formation of iron complex after 20 mins by spectrophotometry,Other,25456077.0,
58,1194113,1,2,,103324254,5369664,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as inhibition of L-DOPA oxidase activity,Other,25782744.0,
59,1259407,1,1,,363899620,5369664,Inactive,,,,,CCRIS mutagenicity studies,Other,,
